Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration

M Perretti1, J D Croxtall, S K Wheller

  • 1Department of Biochemical Pharmacology, William Harvey Research Institute, London, UK.

Nature Medicine
|November 1, 1996
PubMed

Insights

Lipocortin 1 (LC1) is mobilized and externalized from neutrophils upon adhesion, negatively regulating their passage through blood vessel walls during inflammation. This finding reveals a key mechanism in controlling inflammatory cell migration.

Area of Science:

  • Immunology
  • Cell Biology
  • Inflammation Research

Background:

  • Polymorphonuclear leukocyte (PMN) migration is crucial for host defense during inflammation.
  • Endothelial cell and PMN activation increases adhesion molecules, leading to PMN rolling, adherence, and extravasation.
  • Glucocorticoids delay extravasation, suggesting an inhibitory regulatory system exists.

Purpose of the Study:

  • To investigate the role of lipocortin 1 (LC1) in regulating PMN transmigration.
  • To determine if LC1 mobilization and externalization impact PMN responsiveness during extravasation.

Main Methods:

  • Assessed neutrophil transmigration in vivo and in vitro.
  • Analyzed LC1 content and subcellular distribution using FACS, western blotting, and confocal microscopy.
  • Examined LC1 mobilization and externalization following PMN adhesion to endothelial cells.

Main Results:

  • LC1 is mobilized and externalized from PMNs after adhesion to endothelial monolayers (in vitro) and venular endothelium (in vivo).
  • This LC1 externalization negatively regulates PMN transendothelial passage.
  • The findings suggest LC1 acts as an endogenous inhibitor of PMN extravasation.

Conclusions:

  • Lipocortin 1 (LC1) plays a significant inhibitory role in PMN extravasation.
  • LC1 mobilization and externalization represent a key regulatory mechanism controlling inflammatory cell migration.
  • Understanding LC1's function may offer new therapeutic targets for inflammatory diseases.